摘要:
The present invention relates to methods and compositions for treatment of microbial infections and for the enhancement of resistance to infection. The invention comprises administration of an effective amount of bacterial lysate compositions for the treatment of pathological conditions of microbial infections. The present invention can also be used to enhance the immune system to prevent infections by the administration of an effective amount of the compositions.
摘要:
This invention relates to newly identified Staphylococcal polynucleotides, polypeptides encoded by such polynucleotides, the uses of such polynucleotides and polypeptides, as well as the production of such polynucleotides and polypeptides and recombinant host cells transformed with the polynucleotides. This invention also relates to inhibiting the biosynthesis or action of such polynucleotides or polypeptides and to the use of such inhibitors in therapy.
摘要:
Antibodies having Fab regions that specifically bind to Staphylococcus aureus protein A are capable of mediating opsinization of Staphylococcus aureus bacteria despite their expression of antibody-neutralizing protein A. These antibodies and antigen-binding fragments thereof can be used in methods of treating and/or preventing Staphylococcus aureus infections.
摘要:
A preservative efficacy test for determining efficiency of at least one preservative material that is present in a consumable product to reduce or eliminate living microorganisms that includes challenging the preservative material with at least one microorganism derived from a pure culture by inoculating a sample of the product with a quantity of at least one challenge microorganism and allowing the microorganisms to grow for an predetermined interval after which the preservative is neutralized and a portion of the resulting sample is cultured in a testing system that includes at least one testing container, wherein the testing container contains liquid growth media and sensor means capable of monitoring microorganism growth by sensing the metabolic by-products generated by growth of microorganisms present in the liquid growth media and producing an output signal that can be measured and analyzed.
摘要:
A microbiological method for determining traces of antibiotics in low volume biological samples, which comprises determining the minimum inhibitory concentration (MIC) of an antibiotic selected from a group consisting of minocycline, ciprofloxacin, kanamycin, tetracycline and oxacillin against Staphylococcus aureus. The bacteria are grown overnight in Mueller-Hinton broth (MHB), said cultures subsequently being diluted to 0.5 McFarland standard (1.5 x 108 cells/mL). Said antibiotics are then added to 96-well plates to a final volume of 200 µL and incubated at 37°C for 18 hours. Absorbency is determined and the results are expressed as the percentage of inhibition relative to the control containing the biological sample, selected in turn from urine, blood, synovial fluid, eye aqueous humour or cerebrospinal fluid (CSF), and the bacterial culture. The curve representing the percentage of bacterial growth inhibition versus concentration of antibiotic is obtained, and fitted by "Four Parameter Logistic Curve (4PL)" analysis, yielding the antibiotic concentration values in the biological sample. The method allows to determine amounts of antibiotic in the biological sample even at ng/mL level.